{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:49:01Z","timestamp":1782402541994,"version":"3.54.5"},"reference-count":17,"publisher":"American Society of Hematology","issue":"26","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,25]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>A short diagnosis-to-treatment interval independently predicts inferior outcomes in follicular lymphoma. Using international discovery and validation cohorts, we demonstrate its prognostic value beyond established prognostic indices, with implications for risk stratification, clinical trial design, and interpretation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2026033090","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T17:12:31Z","timestamp":1776186751000},"page":"3248-3252","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Diagnosis-to-treatment interval is associated with outcomes in follicular lymphoma treated with immunochemotherapy"],"prefix":"10.1182","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7848-1268","authenticated-orcid":false,"given":"Prokop","family":"Vodi\u010dka","sequence":"first","affiliation":[{"name":"1First Department of Medicine, First Faculty of Medicine Charles University and General Hospital, Prague, Czech Republic"},{"name":"2Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarec Christoffer","family":"El-Galaly","sequence":"additional","affiliation":[{"name":"3Departments of Hematology, Clinical Epidemiology, and Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark"},{"name":"4Department of Hematology, Aalborg University Hospital, Aalborg, Denmark"},{"name":"5Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9861-3117","authenticated-orcid":false,"given":"V\u00edt","family":"Proch\u00e1zka","sequence":"additional","affiliation":[{"name":"6Department of Haemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9524-3990","authenticated-orcid":false,"given":"Christopher R.","family":"Flowers","sequence":"additional","affiliation":[{"name":"7Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4625-3009","authenticated-orcid":false,"given":"Diego","family":"Villa","sequence":"additional","affiliation":[{"name":"8Division of Medical Oncology, BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8231-8183","authenticated-orcid":false,"given":"Caroline E.","family":"Dietrich","sequence":"additional","affiliation":[{"name":"5Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6575-7686","authenticated-orcid":false,"given":"Lasse H.","family":"Jakobsen","sequence":"additional","affiliation":[{"name":"4Department of Hematology, Aalborg University Hospital, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Ghesqui\u00e8res","sequence":"additional","affiliation":[{"name":"9Department of Hematology, H\u00f4pital Lyon Sud, Claude Bernard Lyon 1 University, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3218-3633","authenticated-orcid":false,"given":"Michael R.","family":"Clausen","sequence":"additional","affiliation":[{"name":"10Department of Medicine, Vejle Hospital, Vejle, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0287-7124","authenticated-orcid":false,"given":"Robert","family":"Kridel","sequence":"additional","affiliation":[{"name":"11Princess Margaret Cancer Centre, University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7988-1565","authenticated-orcid":false,"given":"Chan Y.","family":"Cheah","sequence":"additional","affiliation":[{"name":"12Department of Haematology, Sir Charles Gairdner Hospital, Perth, Australia"},{"name":"13Department of Internal Medicine, The University of Western Australia Medical School, Perth, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0376-2559","authenticated-orcid":false,"given":"Eliza A.","family":"Hawkes","sequence":"additional","affiliation":[{"name":"14Olivia Newton-John Cancer Research Institute, Austin Health, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3566-8847","authenticated-orcid":false,"given":"Bj\u00f6rn","family":"Wahlin","sequence":"additional","affiliation":[{"name":"15Department of Hematology, Karolinska University Hospital, Stockholm, Sweden"},{"name":"16Institution for Medicine at Huddinge, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maher K.","family":"Gandhi","sequence":"additional","affiliation":[{"name":"17Translational Research Institute, Mater Research Institute University of Queensland, Brisbane, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa C.","family":"Larson","sequence":"additional","affiliation":[{"name":"2Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot J.","family":"Cahn","sequence":"additional","affiliation":[{"name":"2Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan W.","family":"Friedberg","sequence":"additional","affiliation":[{"name":"18Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Martin","sequence":"additional","affiliation":[{"name":"19Department of Medicine, Weill Cornell Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1153-2294","authenticated-orcid":false,"given":"Dai","family":"Chihara","sequence":"additional","affiliation":[{"name":"20Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2723-6481","authenticated-orcid":false,"given":"Jonathon B.","family":"Cohen","sequence":"additional","affiliation":[{"name":"21Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Habermann","sequence":"additional","affiliation":[{"name":"22Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4998-9932","authenticated-orcid":false,"given":"Carla","family":"Casulo","sequence":"additional","affiliation":[{"name":"18Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1576-8341","authenticated-orcid":false,"given":"Yucai","family":"Wang","sequence":"additional","affiliation":[{"name":"22Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6522-4086","authenticated-orcid":false,"given":"Peter","family":"de Nully Brown","sequence":"additional","affiliation":[{"name":"23Department of Hematology, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9865-4517","authenticated-orcid":false,"given":"Eric","family":"Mou","sequence":"additional","affiliation":[{"name":"24Division of Hematology, Oncology, and Blood and Marrow Transplantation, Department of Internal Medicine, University of Iowa, Iowa City, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Belada","sequence":"additional","affiliation":[{"name":"25Fourth Department of Internal Medicine\u2013Hematology, Faculty of Medicine, Charles University and University Hospital Hradec Kr\u00e1lov\u00e9, Hradec Kr\u00e1lov\u00e9, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Jan\u00edkov\u00e1","sequence":"additional","affiliation":[{"name":"26Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"M\u00f3cikov\u00e1","sequence":"additional","affiliation":[{"name":"27Department of Hematology, Fakultni Nemocnice Kr\u00e1lovsk\u00e9 Vinohrady and Third Faculty of Medicine, Charles University, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5584-584X","authenticated-orcid":false,"given":"Richard","family":"Burack","sequence":"additional","affiliation":[{"name":"28Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9346-9013","authenticated-orcid":false,"given":"Izidore S.","family":"Lossos","sequence":"additional","affiliation":[{"name":"29Division of Hematology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0459-6609","authenticated-orcid":false,"given":"Brad S.","family":"Kahl","sequence":"additional","affiliation":[{"name":"30Division of Oncology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin E.","family":"Smedby","sequence":"additional","affiliation":[{"name":"5Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie H.","family":"Sehn","sequence":"additional","affiliation":[{"name":"8Division of Medical Oncology, BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6952-6073","authenticated-orcid":false,"given":"Marek","family":"Trn\u011bn\u00fd","sequence":"additional","affiliation":[{"name":"1First Department of Medicine, First Faculty of Medicine Charles University and General Hospital, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7482-178X","authenticated-orcid":false,"given":"James R.","family":"Cerhan","sequence":"additional","affiliation":[{"name":"2Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1867-0526","authenticated-orcid":false,"given":"Matthew J.","family":"Maurer","sequence":"additional","affiliation":[{"name":"2Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"16","key":"2026062511215247700_bib1","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1200\/JCO.2017.76.5198","article-title":"Diagnosis-to-treatment interval is an important clinical factor in newly diagnosed diffuse large B-cell lymphoma and has implication for bias in clinical trials","volume":"36","author":"Maurer","year":"2018","journal-title":"J Clin Oncol"},{"issue":"2","key":"2026062511215247700_bib2","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3109\/10428194.2015.1055480","article-title":"Impact of time from diagnosis to initiation of curative chemotherapy on survival of patients with diffuse large B-cell lymphoma","volume":"57","author":"Hay","year":"2016","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"2026062511215247700_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1200\/JCO-25-00892","article-title":"FLIPI24: a modern prognostic model and clinical trial enrichment tool for newly diagnosed follicular lymphoma","volume":"44","author":"Maurer","year":"2025","journal-title":"J Clin Oncol"},{"issue":"3","key":"2026062511215247700_bib4","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/10428194.2018.1508671","article-title":"Prognostic impact of diagnosis to treatment interval (DTI) in diffuse large B-cell lymphoma patients: a real-life monocentric study","volume":"60","author":"Camus","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"suppl 1","key":"2026062511215247700_bib5","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1182\/blood-2024-208852","article-title":"Impact of the diagnosis-to-treatment interval (DTI) on outcomes in older adults with diffuse large B-cell lymphoma (DLBCL) treated in the real-world setting [abstract]","volume":"144","author":"Hamlin","year":"2024","journal-title":"Blood"},{"issue":"suppl 1","key":"2026062511215247700_bib6","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1182\/blood-2023-174715","article-title":"Diagnosis to treatment interval (DTI) informs outcomes across subtypes of aggressive B-cell lymphoma [abstract]","volume":"142","author":"Maurer","year":"2023","journal-title":"Blood"},{"issue":"23","key":"2026062511215247700_bib7","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1200\/JCO.20.02573","article-title":"Short diagnosis-to-treatment interval is associated with higher circulating tumor DNA levels in diffuse large B-cell lymphoma","volume":"39","author":"Alig","year":"2021","journal-title":"J Clin Oncol"},{"issue":"suppl 1","key":"2026062511215247700_bib8","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1182\/blood-2018-99-110231","article-title":"Diagnosis-to-treatment interval as a prognostic factor in aggressive T-cell lymphomas [abstract]","volume":"132","author":"Ollila","year":"2018","journal-title":"Blood"},{"issue":"11","key":"2026062511215247700_bib9","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1182\/bloodadvances.2022009225","article-title":"Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma","volume":"7","author":"Epperla","year":"2023","journal-title":"Blood Adv"},{"issue":"1","key":"2026062511215247700_bib10","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1038\/s41598-021-82615-4","article-title":"Importance of diagnosis-to-treatment interval in newly diagnosed patients with diffuse large B-cell lymphoma","volume":"11","author":"Yoshida","year":"2021","journal-title":"Sci Rep"},{"issue":"6","key":"2026062511215247700_bib11","doi-asserted-by":"crossref","first-page":"719","DOI":"10.6004\/jnccn.2020.7654","article-title":"Shorter diagnosis-to-treatment interval in diffuse large B-cell lymphoma is associated with inferior overall survival in a large, population-based registry","volume":"19","author":"Blunt","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"7","key":"2026062511215247700_bib12","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s00277-020-04099-y","article-title":"The interval between progression and therapy initiation is the key prognostic parameter in relapsing diffuse large B cell lymphoma: analysis from the Czech Lymphoma Study Group database (NIHIL)","volume":"99","author":"Janikova","year":"2020","journal-title":"Ann Hematol"},{"issue":"4","key":"2026062511215247700_bib13","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/bjh.15224","article-title":"Time to treatment is an independent prognostic factor in aggressive non-Hodgkin lymphomas","volume":"181","author":"Olszewski","year":"2018","journal-title":"Br J Haematol"},{"issue":"suppl 1","key":"2026062511215247700_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1182\/blood-2020-138789","article-title":"Diagnosis-to-treatment interval is an important prognostic factor with a time-dependent effect predicting event-free survival after 12 months from first-line treatment in newly diagnosed diffuse large B-cell primary CNS lymphoma [abstract]","volume":"136","author":"Laude","year":"2020","journal-title":"Blood"},{"issue":"20","key":"2026062511215247700_bib15","first-page":"2493","article-title":"Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population","volume":"141","author":"Alduaij","year":"2023","journal-title":"Blood"},{"issue":"1","key":"2026062511215247700_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s40164-025-00666-z","article-title":"Impact of diagnosis to treatment interval on outcomes in patients with newly diagnosed marginal zone lymphoma - a US multisite study","volume":"14","author":"Epperla","year":"2025","journal-title":"Exp Hematol Oncol"},{"issue":"S2","key":"2026062511215247700_bib17","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/hon.84_2631","article-title":"Short diagnosis-to-treatment interval is associated with high risk and poor outcomes in diffuse large B-cell lymphoma","volume":"37","author":"Casan","year":"2019","journal-title":"Hematol Oncol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/26\/3248\/2528536\/blood_bld-2026-033090-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/26\/3248\/2528536\/blood_bld-2026-033090-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:21:59Z","timestamp":1782400919000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/147\/26\/3248\/567758\/Diagnosis-to-treatment-interval-is-associated-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":17,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2026,6,25]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2026033090","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6,25]]},"published":{"date-parts":[[2026,6,25]]}}}